Platelet/Lymphocyte Ratio Predicted Long-Term Prognosis for Acute Upper Extremity Deep Vein Thrombosis from a Retrospective Study

被引:0
|
作者
Liu, Yang [1 ]
Sun, Hongze [1 ]
Jiang, Jianjun [1 ]
机构
[1] Shandong Univ, Qilu Hosp, Dept Gen Surg, Vasc Surg, Jinan 250012, Shandong, Peoples R China
基金
中国国家自然科学基金;
关键词
upper extremity deep vein thrombosis; mortality risk; vena cava filter; malignancy; platelet; lymphocyte ratio; VENA-CAVA FILTERS; VENOUS THROMBOSIS; LYMPHOCYTE RATIO; NEUTROPHIL; PLATELET;
D O I
10.2147/JIR.S399000
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: In this study, we aimed to determine the mortality risk factors and whether placement of a vena cava filter improves the prognosis of acute upper extremity deep vein thrombosis (UEDVT). Methods: Clinical data and follow-up results were retrospectively analyzed. Cox regression analysis was conducted to identify the risk factors associated with all-cause mortality in all patients and subgroups of patients. Results are expressed as hazard ratio (HR) with 95% confidence intervals (95% CI). Receiver operating characteristic curves (ROC) were used to determine the optimal cut-off value. Kaplan-Meier survival curves were constructed and compared by the Log rank test. Results: The study cohort comprised 109 patients of median age 56 years (47.5, 64.5). The median follow-up time was 25 months (8, 47): 39 patients (35.8%) had died by 12 months, 55 (50.5%) by 36 months, and 60 (55%) by the end of follow-up. Presence of 95% CI: 1.15-3.54), and the systemic immune/inflammatory index (SII; HR: 1.471, 95% CI: 1.062-1.991) were identified as independent risk factors for mortality. Subgroup analysis of patients with malignancy determined gender (HR: 2.936, 95% CI: 1.599-5.393) and PLR (HR: 1.427,95% CI: 1.023-1.989) as independent risk factors. Kaplan-Meier analysis showed that the mortality rate was much higher in patients with malignancy, high D-dimer (> 0.92ug/mL), high PLR (> 291) and high SII (> 1487). However, there was no significant difference between patients with and without vena cava filters. Conclusion: In this study, we identified PLR as an new independent predictor of mortality in patients with acute UEDVT. Emergency placement of a vena cava filter did not improve long-term prognosis.
引用
收藏
页码:225 / 234
页数:10
相关论文
共 50 条
  • [41] LONG-TERM MORBIDITY AFTER DEEP-VEIN THROMBOSIS (DVT)
    WIDMER, LK
    WIDMER, MT
    ZEMP, E
    DUCKERT, F
    MARBET, G
    SCHMITT, HE
    BRANDENBERG, E
    VOELIN, R
    THROMBOSIS AND HAEMOSTASIS, 1987, 58 (01) : 53 - 53
  • [42] Deep Vein Thrombosis Prophylaxis in Long-Term Care: Change with the Times?
    Dharmarajan, T. S.
    Norkus, Edward P.
    JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2011, 12 (04) : 313 - 314
  • [43] Venous stasis syndrome: the long-term burden of deep vein thrombosis
    Heit, JA
    HOSPITAL MEDICINE, 2003, 64 (10): : 593 - 598
  • [44] Recurrent Deep Vein Thrombosis Long-Term Incidence and Natural History
    Labropoulos, Nicos
    Jen, James
    Jen, Henry
    Gasparis, Antonios P.
    Tassiopoulos, Apostolos K.
    ANNALS OF SURGERY, 2010, 251 (04) : 749 - 753
  • [45] Sex differences in long-term outcomes of patients with deep vein thrombosis
    Chan, Shin Mei
    Brahmandam, Anand
    Valcarce-Aspegren, Marcus
    Zhuo, Haoran
    Zhang, Yawei
    Tonnessen, Britt H.
    Lee, Alfred, I
    Chaar, Cassius Iyad Ochoa
    VASCULAR, 2023, 31 (05) : 994 - 1002
  • [46] Deep vein thrombosis in upper extremities: clinical characteristics, management strategies and long-term outcomes from the COMMAND VTE Registry
    Yamashita, Y.
    Morimoto, T.
    Amano, H.
    Takase, T.
    Hiramori, S.
    Kim, K.
    Oi, M.
    Murata, K.
    Tsuyuki, Y.
    Sakamoto, J.
    Yoshikawa, Y.
    Shiomi, H.
    Makiyama, T.
    Ono, K.
    Kimura, T.
    EUROPEAN HEART JOURNAL, 2019, 40 : 2433 - 2433
  • [47] Deep vein thrombosis in upper extremities: Clinical characteristics, management strategies and long-term outcomes from the COMMAND VTE Registry
    Yamashita, Yugo
    Morimoto, Takeshi
    Amano, Hidewo
    Takase, Toru
    Hiramori, Seiichi
    Kim, Kitae
    Oi, Maki
    Akao, Masaharu
    Kobayashi, Yohei
    Toyofuku, Mamoru
    Izumi, Toshiaki
    Tada, Tomohisa
    Chen, Po-Min
    Murata, Koichiro
    Tsuyuki, Yoshiaki
    Saga, Syunsuke
    Nishimoto, Yuji
    Sasa, Tomoki
    Sakamoto, Jiro
    Kinoshita, Minako
    Togi, Kiyonori
    Mabuchi, Hiroshi
    Takabayashi, Kensuke
    Yoshikawa, Yusuke
    Shiomi, Hiroki
    Kato, Takao
    Makiyama, Takeru
    Ono, Koh
    Kimura, Takeshi
    THROMBOSIS RESEARCH, 2019, 177 : 1 - 9
  • [48] Efficacy and safety of rivaroxaban for the treatment of PICC-related upper extremity deep vein thrombosis in cancer patients: a retrospective study
    Jiaxuan Xu
    Guodong Wang
    Xiaojie Chen
    Yanfen Shen
    Xinpeng Wang
    Hongzhi Wang
    Thrombosis Journal, 21
  • [49] Efficacy and safety of rivaroxaban for the treatment of PICC-related upper extremity deep vein thrombosis in cancer patients: a retrospective study
    Xu, Jiaxuan
    Wang, Guodong
    Chen, Xiaojie
    Shen, Yanfen
    Wang, Xinpeng
    Wang, Hongzhi
    THROMBOSIS JOURNAL, 2023, 21 (01)
  • [50] Upper extremity deep vein thrombosis in hospitalized central venous catheter carriers and non-carriers: A retrospective cohort study
    Novalbos-Partida, Jose angel
    Rueda-Camino, Jose Antonio
    Angelina-Garcia, Maria
    Joya-Seijo, M. Dolores
    Trujillo-Luque, Davinia
    Barba-Martin, Raquel
    MEDICINA CLINICA, 2025, 164 (03): : 129 - 132